View Document Preview and Link Document Date: 2014-06-02 23:14:34 Open Document File Size: 305,95 KB Share Result on Facebook
City Rosenstein / Washington / DC / Philadelphia / Canberra / Victoria / Offit / Orenstein / Apicella / / Company Novartis / NNDSS Annual Report Writing Group / 4CMenB / Baxter / MOSAIC / Pfizer / GlaxoSmithKline / Plotkin SA / New England Journal / New Zealand Medical Journal / Serogroup / Sanofi / Australian Technical Advisory Group / Novartis Vaccines & Diagnostics Pty. Ltd. / Stephens / / Continent Australia / / Country Saudi Arabia / New Zealand / Australia / United Kingdom / Wales / / IndustryTerm age / treatment of meningococcal disease / prevention of vaccine-preventable diseases / / MedicalCondition photophobia / epiglottitis / JE / viral infection / headache / epidemic / arthritis / complement disorders / nausea / Primary meningococcal conjunctivitis / tetanus / anaphylaxis / limb deformity / conjunctivitis / Meningococcal disease / Septicaemia / deafness / certain disorders / epidemics / meningococcal septicaemia / pericarditis / pneumonia / invasive meningococcal disease / disease Meningococcal disease / INFORMATION FOR IMMUNISATION PROVIDERS Disease / disease / Y. Meningococcal disease / sporadic meningococcal disease / erythema / fever / C disease / vomiting / sporadic and epidemic disease / meningococcal infection / diseases / infectious diseases / muscle aches / infection / deficiency / epidemiology Meningococcal disease / rash / meningitis / joint pain / disorders / MenB disease / / MedicalTreatment Immunization / immunization schedules / antibiotics / vaccination / vaccinations / organ transplant / / Organization World Health Organization / National Science Foundation / Centers for Disease Control and Prevention / Department of Health / state/territory public health authority / / Position Governor / Major / Private / / ProgrammingLanguage C / / ProvinceOrState Nebraska / Maryland / Washington / Montana / Massachusetts / / PublishedMedium Infection and Immunity / New England Journal of Medicine / / Region sub-Saharan Africa / New England / / Technology antibodies / pdf / / URL www.cdc.gov/meningococcal / www.who.int/csr/disease/meningococcal/en / www.immunise.health.gov.au / www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/PI / http / SocialTag 
MENINGOCOCCAL VACCINES FOR AUSTRALIANS: INFORMATION FOR IMMUNISATION PROVIDERS Disease and epidemiology Meningococcal disease is rare but serious. Septicaemia and/or meningitis are the most common clinical manifestations